While the job of the FDA is to protect the public from ineffective drugs, patients in need of life-saving treatments push for accelerated approval of specialty drugs.
Specialty Pharmacy
Advertisement
Drug combination increases the efforts of killing cancer cells.
Advertisement
Predicting the evolution of HIV surface proteins could be used to develop better vaccines.
Final data demonstrates the meaningful impact nusinersen can have on children with later-onset spinal muscular atrophy.
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.
Top news of the day from across the health care landscape.
Advertisement
Litigation to continue surrounding biological mechanisms of dupilumab (Dupixent).
Top news of the week in oncology and cancer drug development.
Tool could improve detection of cancer, bacterial and viral infections.
Renflexis approved to treat multiple conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis.
Advertisement
Real world observational study supports data on sustained hepatitis C virologic response rates.
Early detection found to improve survival in bowel cancer.
Rebekah L. Hanson, PharmD, BCPS, BCACP, discusses the elements of an effective patient management program in specialty pharmacy.
Top five articles of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
2D material nanopores are able to map DNA methylations.
Pharmacy benefit manager reduced prescription drug spending among injured workers.
Hypermutated HIV suppresses immune response.
Glecaprevir/pibrentasvir achieved 99% sustained virologic response rate in patients with chronic HCV with compensated cirrhosis.
Findings could help improve treatment efficacy for patients with ALL.
Marc O'Connor, COO and Chief Strategy Officer at Curant Health, discusses how pharmacies can help patients manage high drug costs.
Combination therapy may lead to more effective cancer treatments.
Aneuploidy can cause many types of cancer and genetic disorders, such as Down syndrome.
Top news of the day from across the health care landscape.
Multiple myeloma survivor seeks to empower patients by illustrating the value of human life.
Decline in cancer incidence rates most likely driven by modern antiretroviral therapies.
MicroRNA 506 triggers autophagy-related cell death in pancreatic cancer cells.
Novel test can detect circulating tumor DNA to determine if a patient has metastatic melanoma.
Hyper-sensitive test detects tumors earlier than current technology.
Top news of the day from across the health care landscape.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Report Details Rising Incidence of Invasive Lobular Carcinoma
2
Breaking News: AstraZeneca, White House Announce Most-Favored-Nation Deal
3
The 3 Skills You Will Need Most
4
FDA Approves Expanded Indication for Risperidone Extended-Release Injectable to Treat Bipolar I Disorder
5
